Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Capital Expenditures (2020 - 2025)

LifeStance Health (LFST) has disclosed Capital Expenditures for 6 consecutive years, with $10.9 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 73.16% to $10.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.1 million through Dec 2025, up 67.51% year-over-year, with the annual reading at $36.1 million for FY2025, 67.51% up from the prior year.
  • Capital Expenditures for Q4 2025 was $10.9 million at LifeStance Health, up from $10.3 million in the prior quarter.
  • The five-year high for Capital Expenditures was $38.7 million in Q4 2021, with the low at $5.1 million in Q3 2024.
  • Average Capital Expenditures over 5 years is $12.6 million, with a median of $10.3 million recorded in 2022.
  • Peak annual rise in Capital Expenditures hit 151.87% in 2022, while the deepest fall reached 73.15% in 2022.
  • Over 5 years, Capital Expenditures stood at $38.7 million in 2021, then tumbled by 73.15% to $10.4 million in 2022, then increased by 9.92% to $11.4 million in 2023, then crashed by 44.8% to $6.3 million in 2024, then soared by 73.16% to $10.9 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $10.9 million, $10.3 million, and $7.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.